Header Logo

Connection

Alane Izu to Adult

Back to Details
This is a "connection" page, showing publications Alane Izu has written about Adult.
Alane Izu
Connection Strength
0,340
Adult
  1. T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and postpartum women living with and without HIV in South Africa. Sci Rep. 2024 09 02; 14(1):20348.
    View in: PubMed
    Score: 0,027
  2. Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005). Vaccine. 2023 05 26; 41(23):3486-3492.
    View in: PubMed
    Score: 0,025
  3. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
    View in: PubMed
    Score: 0,022
  4. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 05 20; 384(20):1885-1898.
    View in: PubMed
    Score: 0,021
  5. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
    View in: PubMed
    Score: 0,021
  6. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
    View in: PubMed
    Score: 0,021
  7. COVID-19 lockdowns in low- and middle-income countries: Success against COVID-19 at the price of greater costs. S Afr Med J. 2020 06 19; 110(8):724-726.
    View in: PubMed
    Score: 0,020
  8. Maternal and neonatal vitamin D status at birth in black South Africans. S Afr Med J. 2019 Sep 30; 109(10):807-813.
    View in: PubMed
    Score: 0,019
  9. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions. Vaccine. 2019 05 16; 37(22):2967-2974.
    View in: PubMed
    Score: 0,019
  10. Causes of stillbirths among women from South Africa: a prospective, observational study. Lancet Glob Health. 2019 04; 7(4):e503-e512.
    View in: PubMed
    Score: 0,019
  11. Predicting Prognosis of Patients with Chronic Subdural Hematoma: A New Scoring System. World Neurosurg. 2018 Jan; 109:e707-e714.
    View in: PubMed
    Score: 0,017
  12. Serotype-Specific Cell-Mediated Immunity Associated With Clearance of Homotypic Group B Streptococcus Rectovaginal Colonization in Pregnant Women. J Infect Dis. 2016 06 15; 213(12):1923-6.
    View in: PubMed
    Score: 0,015
  13. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
    View in: PubMed
    Score: 0,015
  14. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis. Lancet Infect Dis. 2015 Sep; 15(9):1066-1076.
    View in: PubMed
    Score: 0,014
  15. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants. J Infect Dis. 2015 Dec 15; 212(12):1976-87.
    View in: PubMed
    Score: 0,014
  16. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women. J Infect Dis. 2015 Aug 01; 212(3):453-62.
    View in: PubMed
    Score: 0,014
  17. Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLoS One. 2013; 8(8):e72794.
    View in: PubMed
    Score: 0,013
  18. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine. J Infect Dis. 1999 Nov; 180(5):1700-3.
    View in: PubMed
    Score: 0,005
  19. An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates. Vaccine. 1999 Aug 06; 17(23-24):2999-3006.
    View in: PubMed
    Score: 0,005
  20. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA. 1999 Jul 28; 282(4):331-40.
    View in: PubMed
    Score: 0,005
  21. A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant. Vaccine. 1999 Jul 16; 17(22):2769-78.
    View in: PubMed
    Score: 0,005
  22. Treatment of steroid-dependent asthma with recombinant interferon-gamma. Clin Exp Allergy. 1993 Sep; 23(9):785-90.
    View in: PubMed
    Score: 0,003
  23. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993 Feb; 28(2 Pt 1):189-97.
    View in: PubMed
    Score: 0,003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.